SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+12.42%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$215M
AUM Growth
+$215M
(+2.4%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
32.15%
Holding
71
New
17
Increased
13
Reduced
23
Closed
12
Top Buys
| 1 |
Baxter International
BAX
|
$5.71M |
| 2 |
Revvity
RVTY
|
$5.23M |
| 3 |
Zimmer Biomet
ZBH
|
$4.88M |
| 4 |
HCA Healthcare
HCA
|
$4.67M |
| 5 |
Abbott
ABT
|
$4.44M |
Top Sells
| 1 |
iShares Biotechnology ETF
IBB
|
$9.29M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.42M |
| 3 |
Gilead Sciences
GILD
|
$5.73M |
| 4 |
AstraZeneca
AZN
|
$4.52M |
| 5 |
Centene
CNC
|
$4.28M |
Sector Composition
| 1 | Healthcare | 88.35% |
| 2 | Financials | 3.26% |
| 3 | Energy | 1.24% |
| 4 | Consumer Staples | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.71M | 3.59% |
55,000
+15,000
| +38% | +$2.1M |
|
2
UnitedHealth
UNH
$281B
| $7.38M | 3.44% |
45,000
| – | – |
|
3
Elevance Health
ELV
$71.8B
| $7.24M | 3.37% |
43,795
-6,205
| -12% | -$1.03M |
|
4
Humana
HUM
$36.5B
| $7.22M | 3.36% |
35,000
-3,382
| -9% | -$697K |
|
5
Cigna
CI
$80.3B
| $7.11M | 3.31% |
48,504
-1,506
| -3% | -$221K |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $7M | 3.26% |
54,900
-5,100
| -9% | -$650K |
|
7
Eli Lilly
LLY
$657B
| $6.73M | 3.13% |
80,000
+50,000
| +167% | +$4.21M |
|
8
Incyte
INCY
$16.5B
| $6.68M | 3.11% |
50,000
-5,000
| -9% | -$668K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.06M | 2.82% |
50,000
-10,000
| -17% | -$1.21M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $5.91M | 2.75% |
47,500
-20,000
| -30% | -$2.49M |
|
|
11
Baxter International
BAX
$12.7B
| $5.71M | 2.66% |
+110,000
| New | +$5.71M |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $5.47M | 2.55% |
50,000
+10,000
| +25% | +$1.09M |
|
13
Universal Health Services
UHS
$11.6B
| $5.29M | 2.46% |
42,500
+7,500
| +21% | +$933K |
|
|
14
Revvity
RVTY
$10.5B
| $5.23M | 2.43% |
+90,000
| New | +$5.23M |
|
15
Boston Scientific
BSX
$156B
| $4.97M | 2.32% |
200,000
+25,000
| +14% | +$622K |
|
|
16
Zimmer Biomet
ZBH
$21B
| $4.88M | 2.27% |
+40,000
| New | +$4.88M |
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.83M | 2.25% |
55,000
-5,000
| -8% | -$439K |
|
18
Merck
MRK
$210B
| $4.77M | 2.22% |
75,000
-40,000
| -35% | -$2.54M |
|
19
Agilent Technologies
A
$35.7B
| $4.76M | 2.22% |
90,000
+55,000
| +157% | +$2.91M |
|
|
20
HCA Healthcare
HCA
$94.5B
| $4.67M | 2.18% |
+52,500
| New | +$4.67M |
|
|
21
Centene
CNC
$14.3B
| $4.63M | 2.16% |
65,000
-60,000
| -48% | -$4.28M |
|
22
McKesson
MCK
$85.4B
| $4.45M | 2.07% |
30,000
-5,000
| -14% | -$741K |
|
|
23
Abbott
ABT
$231B
| $4.44M | 2.07% |
+100,000
| New | +$4.44M |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.26M | 1.98% |
35,200
+7,500
| +27% | +$907K |
|
25
Bristol-Myers Squibb
BMY
$96B
| $4.21M | 1.96% |
77,400
-47,600
| -38% | -$2.59M |
|